Baxter International (BAX) announced it has filed a registration statement with the SEC regarding its planned spinoff of its biopharmaceutical business called Baxalta. The company will focus on developing and marketing innovative biopharmaceuticals. Source , Link to Registration Statement (Will open PDF)
